Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17β-estradiol

Journal of the National Cancer Institute

Volumn 93, Issue 22, 2001, Pages 1714-1723

  Song, Robert X D ^a   Mor, Gil ^b   Naftolin, Fred ^b   McPherson, Robert A ^a   Song, Joon ^b   Zhang, Zhenguo ^a   Yue, Wei ^a   Wang, JiPing ^a   Santen, Richard J ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CASPASE INHIBITOR; DNA FRAGMENT; ESTRADIOL; ESTROGEN; FAS ANTIGEN; FAS LIGAND; FULVESTRANT; LIPOCORTIN 5; RECEPTOR PROTEIN; SEX HORMONE;

APOPTOSIS; ARTICLE; ASSAY; BREAST CANCER; CANCER HORMONE THERAPY; CELL COUNT; CELL GROWTH; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STATISTICAL ANALYSIS; TUMOR REGRESSION; WESTERN BLOTTING;

EID: 0035930095     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.22.1714     Document Type: Article

References (40)

1. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer
2. Massive estrogen administration in premenopausal women with breast cancer
3. Diethylstilbestrol: Recommended dosages for different categories of breast cancer patients
4. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer
5. Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis
6. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo
7. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
8. Aromatase within the breast
9. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
10. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells
11. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
12. A matter of life and cell death
13. Estrogen causes cell death of estrogen receptor stably transfected cells via apoptosis
14. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice
15. Death receptors: Signaling and modulation
16. The Fas/Fas-ligand system: A mechanism for immune evasion in human breast carcinomas
17. Roles of Fas and Fas ligand during mammary gland remodeling
18. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer
19. Regulation of fas ligand expression in breast cancer cells by estrogen: Functional differences between estradiol and tamoxifen
20. Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variants
21. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens
22. Early detection of apoptosis using a fluorescent conjugate of annexin V
23. Assessment of DNA damage in apoptosis
24. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells
25. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells
26. Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells
27. Expression of Fas and Fas ligand in normal and ischemia-reperfusion testes: Involvement of the Fas system in the induction of germ cell apoptosis in the damaged mouse testis
28. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system
29. Mechanisms of apoptosis by c-Myc
30. MAP kinase pathways
31. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2
32. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo
33. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis
34. A Myc-induced apoptosis pathway surfaces
35. Functional MycMax heterodimer is required for activation-induced apoptosis in T cell hybridomas
36. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice
37. Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis
38. Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle
39. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
40. Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line